scispace - formally typeset
Search or ask a question
Journal ArticleDOI

A GFP-based method facilitates clonal selection of transfected CHO cells.

01 Jan 2010-Biotechnology Journal (WILEY‐VCH Verlag)-Vol. 5, Iss: 1, pp 24-31
TL;DR: A method based on the co‐expression of enhanced green fluorescent protein (EGFP) that allows clonal selection in standard 96‐well cell culture plates and is an alternative to the identification of high‐producer clones using various cell sorting methods is presented.
Abstract: The identification of highly expressing clones is a crucial step in the development of cell lines for production of recombinant proteins. Here we present a method based on the co-expression of enhanced green fluorescent protein (EGFP) that allows clonal selection in standard 96-well cell culture plates. The genes encoding the EGFP protein and the protein of interest are linked by an internal ribosome entry site and thus are transcribed into the same mRNA but are translated independently. Since both proteins arise from a common mRNA, the EGFP expression level correlates with the expression level of the therapeutic protein for each clone. By expressing recombinant growth factors in CHO cells, we demonstrate the robustness and performance of this technique. The method is an alternative to the identification of high-producer clones using various cell sorting methods, as it can be performed with standard laboratory equipment.

Summary (2 min read)

Introduction

  • A key step in the generation of cell lines for the efficient production of recombinant proteins is the selection of high producer clones following transfection and selection [1].
  • The process of randomly picking a large number of clones produced, e.g. by limited dilution, and assaying them individually by ELISA is tedious, time consuming, and reportedly not always very effective [2,3].
  • Moreover, this method does not account for differences in either cell density or media volume between wells.
  • The enhanced green fluorescent protein (EGFP) has been suggested in the past as co-expressed indicator protein for applications in FACS-based cell separation, but also for the screening of cultures in multiwell plates [8-10].
  • The titres are assumed to be linked.

Materials and Methods

  • Materials 96-well plates used for screening were from Nunc, Wiesbaden, Germany (96 F TC Nunclon) and BD-Falcon, Heidelberg, Germany (Microtest 96).
  • Chemicals were from established suppliers such as Sigma Aldrich and used as received.
  • High quality water was produced by a Millipore unit.
  • Cell culture Chinese Hamster Ovary cells (cell line CHO-K1 (CCL-61, ATCC)) were maintained in growth medium (R10: RMPI 1640 medium supplemented with L-glutamine (2 mM), penicillin/streptomycin (0.1 mg/mL) and 10 % foetal calf serum) in an atmosphere of 5.0 % CO2 and at 37 °C (incubator: Forma Steri-Cult or Forma Direct-Heat, ThermoFisher Scientific, Dreieich, Germany).
  • Prior to the spinner (IIBS, Chur, Switzerland) experiments, the adherent cells were adapted to cultivation in suspension.

Plasmid construction

  • The coding regions of the human growth factors VEGFA and IGF1A were amplified by RTPCR as follows, using total human RNA from Saos-2 and HEK293 as template.
  • The PCR products were purified and subcloned into pGEMT-Easy (Promega, Mannheim, Germany).
  • After 48 h, the cells were collected by trypsinisation and the transfection efficiency was roughly estimated via the EGFP fluorescence by flow cytometry in a Cytomics FC500 (Beckman Coulter, Krefeld, Germany).
  • The basis for this method is a dilution of the cell suspension to a point were statistically less than one cell per well (here 0.6) are plated.
  • The concentration of hVEGFA and hIGF1A in cell culture supernatants were determined using the specific ELISA development kits from Peprotech (London, UK) and from R&D systems (Wiesbaden, Germany) according to the manufacturer’s instructions.

Results and discussions

  • In the pEGFP-N1-based gene constructs used here, the genes encoding for the recombinant target protein and for EGFP are linked by an internal ribosome entry site (IRES).
  • Moreover, the use of pEGFP-N1 for transgene expression besides good product titres also makes possible the screening strategy developed in this contribution Determination of optimal screening parameters.
  • Both examined types of transparent microplates exhibited a rather high background fluorescence, if compared to values given by the suppliers for the special fluorescence plates.
  • The detected fluorescence values were in the range of BFplate, indicating that the contribution of the non-transfected cells to the measured fluorescence is low and does not depend on the number of cells per well.
  • Nunc plates were thus used in the subsequent measurements.

Screening for high producers

  • In order to test the method for clone screening, CHO cells were transfected with pEGFPhVEGFA or pEGFP-hIGF1A.
  • Subsequently, the transfected cells were cultivated for two weeks under selection pressure before being subjected to limited dilution into 96-well plates.
  • The intensity of the EGFP fluorescence was in the same range for all the investigated clones, the quantity of secreted hVEGFA was ten-fold higher than that of hIFG1A.

Conclusions

  • The use of a recombinant bicistronic plasmid to express the protein of interest along with EGFP allows for a fast screening for “high producers” via the EGFP fluorescence.
  • The screening can be performed in standard transparent microtitre plates and less than 3000 EGFP expressing cells can be detected.
  • The new screening method allows an efficient detection of good producer clones at an early stage of the process development.
  • As it does not rely on fluorescence-activated cell sorting, nor does it require the availability of an antibody specific for the therapeutic protein to be expressed, it can be easily implemented in any laboratory and stage of the cell line development process.
  • Eva Weiss and Nicole Andersen provided technical support.

Did you find this useful? Give us your feedback

Content maybe subject to copyright    Report

HAL Id: hal-00514309
https://hal.archives-ouvertes.fr/hal-00514309
Submitted on 2 Sep 2010
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entic research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diusion de documents
scientiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
A GFP-based method facilitates clonal selection of
transfected CHO cells
Denise Freimark, Valérie Jérôme, Ruth Freitag
To cite this version:
Denise Freimark, Valérie Jérôme, Ruth Freitag. A GFP-based method facilitates clonal selec-
tion of transfected CHO cells. Biotechnology Journal, Wiley-VCH Verlag, 2009, 4 (10), pp.24.
�10.1002/biot.200800264�. �hal-00514309�

For Peer Review
A GFP-based method facilitates clonal selection of
transfected CHO cells
Journal:
Biotechnology Journal
Manuscript ID:
BIOT-2008-0264.R2
Wiley - Manuscript type:
Technical Report
Date Submitted by the
Author:
22-Jun-2009
Complete List of Authors:
Freimark, Denise; University of Bayreuth, Chair for Process
Biotechnology
Jérôme, Valérie; University of Bayreuth, Chair for Process
Biotechnology
Freitag, Ruth; Lehrstuhl Bioprozesstechnik, Universität Bayreuth
Keywords:
growth factor, high producer, mammalian cell culture, recombinant
protein production, transfection
Wiley-VCH
Biotechnology Journal

For Peer Review
Page 1 of 19
Technical Report ((4783 words))
A GFP-based method facilitates clonal selection of transfected
CHO cells
Denise Freimark, Valérie Jérôme and Ruth Freitag*
Chair for Process Biotechnology University of Bayreuth, Germany
Key words: growth factor, high producer, mammalian cell culture, recombinant protein
production, transfection
*corresponding author: Chair for Process Biotechnology, University of Bayreuth, 95440
Bayreuth, Germany, phone: 0049 921 55-7371, Fax: 0049 921 55-7375, e-mail:
bioprozesstechnik@uni-bayreuth.de
Abbreviations:
BSA: Bovine serum albumin
CHO: Chinese hamster ovary
EGFP: Enhanced green fluorescent protein
FACS: Fluorescence assisted cell sorting
G418: Geneticin (antibiotic used for screening)
hIGFIA: Human insulin-like growth factor 1A
IRES: Internal ribosome entry site
hVEGFA: Human vascular endothelial growth factor A
Page 1 of 23
Wiley-VCH
Biotechnology Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

For Peer Review
Page 2 of 19
Abstract
The identification of highly expressing clones is a crucial step in the development of cell lines
for production of recombinant proteins. Here we present a method based on the co-expression
of enhanced GFP that allows clonal selection in standard 96-well cell culture plates. The
genes encoding the EGFP protein and the protein of interest are linked by an internal
ribosome entry site and thus are transcribed into the same mRNA but are translated
independently. Since both proteins arise from a common mRNA, the EGFP expression level
correlates with the expression level of the therapeutic protein for each clone. By expressing
recombinant growth factors in CHO cells, we demonstrate the robustness and performance of
this technique. The method is an alternative to the identification of high-producer clones using
various cell sorting methods, as it can be performed with standard laboratory equipment.
Page 2 of 23
Wiley-VCH
Biotechnology Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

For Peer Review
Page 3 of 19
Introduction
A key step in the generation of cell lines for the efficient production of recombinant proteins
is the selection of high producer clones following transfection and selection [1]. Most often,
successfully transfected cells pass through a subcloning stage using 96-well plates. A robust
method for screening at this level is valuable, as it helps to focus on good producers early on.
Analysis of the product titre in cell culture supernatant by ELISA is commonly used at this
stage to identify clones secreting high levels of recombinant protein. However, the process of
randomly picking a large number of clones produced, e.g. by limited dilution, and assaying
them individually by ELISA is tedious, time consuming, and reportedly not always very
effective [2,3]. Moreover, this method does not account for differences in either cell density
or media volume between wells. Apart from the already mentioned tediousness, this approach
may therefore not accurately predict the clones with high specific productivity.
High throughput screening methods based, e.g., on fluorescence-activated cell sorting (FACS)
or magnetic bead-based cell separation are faster [4,5], but require, especially in case of
FACS, not only expensive equipment but also highly skilled operators. Hence such methods
tend to be restricted to labs in frequent need of cell sorting. Moreover, unless the target
molecule itself shows fluorescence, labelling or co-expression of a fluorescent or otherwise
detectable molecule is required [6,7]. The enhanced green fluorescent protein (EGFP) has
been suggested in the past as co-expressed indicator protein for applications in FACS-based
cell separation, but also for the screening of cultures in multiwell plates [8-10]. In this
approach the recombinant cells express both the fluorescent and the target protein, the titres
are assumed to be linked. However, mostly the genes for EGFP and the target protein were
co-transfected into the cells via individual plasmids, e.g. [9,11]. Hence no physical connection
between the expression of the two proteins existed.
Page 3 of 23
Wiley-VCH
Biotechnology Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

Citations
More filters
Journal ArticleDOI
TL;DR: This review covers existing technology and recent progress made in improving various aspects of the stable cell line generation process for mAb production.
Abstract: Clinical effectiveness has driven the commercial success of monoclonal antibody (mAb) products. Mammalian cells are currently the preferred system for large-scale production as the mAbs produced are biochemically similar to human forms. The cell line generation process is tedious and time-consuming as clones with high productivity, stable long-term expression and good product quality are rare occurrences. Cell line generation efficiency and mAb quality can be improved through host cell engineering, vector optimization and high-throughput clone selection. Targeted integration into predetermined sites on the chromosome is a promising new area being explored. This review covers existing technology and recent progress made in improving various aspects of the stable cell line generation process for mAb production.

40 citations

Journal ArticleDOI
TL;DR: A novel strategy to identify higher productivity cells at the FACS step by leveraging a simple viable cell staining method that detects mitochondrial membrane potential (Ψm), a key indicator of cellular metabolic activity.

13 citations

Journal ArticleDOI
TL;DR: The cell‐free system thus approached productivities for the active (renatured) protein previously only recorded for bacterial hosts, while assuring comprehensive post‐translational processing.
Abstract: The human bone morphogenetic protein-2 (hBMP2) is a glycoprotein, which induces de novo bone formation. Here, recombinant production in stably transfected Chinese Hamster Ovary (CHO) cells is compared to transient expression in Human Embryo Kidney (HEK) cells and cell-free synthesis in CHO cell lysates containing microsomal structures as sites of post-translational processing. In case of the stably transfected cells, growth rates and viabilities were similar to those of the parent cells, while entry into the death phase of the culture was delayed. The maximum achievable rhBMP2 concentration in these cultures was 153 pg mL−1. Up to 280 ng mL−1 could be produced in the transient expression system. In both cases the rhBMP-2 was found to interact with the producer cells, which presumably contributed to the low yields. In the cell-free system, hBMP2 yields could be increased to almost 40 μg mL−1, reached within 3 hours. The cell-free system thus approached productivities for the active (renatured) protein previously only recorded for bacterial hosts, while assuring comprehensive post-translational processing. This article is protected by copyright. All rights reserved

12 citations


Cites methods from "A GFP-based method facilitates clon..."

  • ...The recombinant cell line 4D6 was derived from the CHO-K1 parent cell line by transfection with phBMP2-EGFP, using PEI as transfection agent, followed by G418-selection and EGFP-based screening/adaptation to suspension culture as previously described [30]....

    [...]

  • ...EGFP expression was measured as previously described by flow cytometry [31] or spectrophotometrically [30]....

    [...]

Book ChapterDOI
01 Jan 2015
TL;DR: This chapter will provide a summary of the methodology and strategies employed to select the desired cell lines that meet the demands of the biopharmaceutical manufacturing environment from manual selection to automated systems that aid in the mammalian cell line selection process.
Abstract: With the increase in mammalian cell-expressed recombinant biotherapeutics, the process of accelerating the selection of generated stable mammalian cell lines is becoming a critical step in cell line development pipelines. The selection process is known to be a major bottleneck in obtaining a cell line from development into manufacturing, but with the current sales of biotherapeutics reaching close to US$125 billion with monoclonal antibodies being more than 50 % of the sales, there is no sign of a decrease in demand and the amount of cell line development projects in the pipeline will keep increasing. This means that more efficient cost effective cell line selection strategies are critical to meet demand for affordable biologics. The current advancements in the cell line selection process has helped in this regard, by reducing some of the labor and time required to reduce heterogeneity and determine clonality of a cell line expressing a quality biotherapeutic protein at the highest specific productivity possible. However, challenges remain in dealing with the sheer volume of cells that need to go through the screening process for the determination of a stable highly productive clone. This chapter will provide a summary of the methodology and strategies employed to select the desired cell lines that meet the demands of the biopharmaceutical manufacturing environment from manual selection to automated systems that aid in the mammalian cell line selection process.

10 citations

Dissertation
01 May 2015
TL;DR: This study illustrates that effective cell line and process development for DTE protein production requires a synergistic combination of vector, cell and process engineering strategies designed to alleviate cellular bottlenecks simultaneously, enabling the host cell to attain both high qP and cell density.
Abstract: Despite the remarkable yield improvements of recombinant proteins produced in mammalian cells, some “difficult-to-express” (DTE) proteins achieve considerably lower production titres. The bottlenecks are exacerbated in the case of transient gene expression (TGE) systems as the host cells are easily overloaded with recombinant genes, hence necessitating intensive cell line and process development. The aims of this thesis are to study the limitations to high TGE yields of DTE proteins, and subsequently investigate strategies to efficiently alleviate the bottlenecks. For this purpose, we used a model DTE Fc-fusion protein (Sp35:Fc; proprietary of Biogen Idec) expressed in Chinese hamster ovary (CHO) cells, as well as secreted alkaline phosphatase and green fluorescent protein for comparisons. Through analyses of intracellular and extracellular Sp35:Fc polypeptides, we found that post-translational mechanisms were limiting in the cells. The saturation of Sp35:Fc expression coincided with the retention of folded proteins in the ER and the increase in disulphide bonded aggregates. Further in silico analysis via a mathematical model enabled identification of the relative importance of specific cellular process on Sp35:Fc productivity (qP). Based on these observations, three strategies aimed at improving the transient production of Sp35:Fc were investigated. The first strategy involved the evaluation of functional performance of clonally derived cell populations to produce Sp35:Fc. We critically assessed the key intrinsic functional traits of the clones, and their impact on Sp35:Fc production. The data indicate that cell lines with the capability to accumulate high biomass while maintaining relatively high specific growth rate (µ) were likely to be high producers for DTE proteins. For the second strategy, we utilised a novel vector system specifically beneficial for DTE proteins by incorporating ER stress response elements (ERSE) into the SV40 vector expressing Sp35:Fc or the UPR transactivator ATF6c. The ERSE-SV40 vectors acted as a synthetic "amplifier/dual activator" circuit, where expressed ATF6c amplified both its own and Sp35:Fc expression via activation of ERSE-SV40, whilst generally transactivating cellular ER capacity via endogenous ERSE. In the third approach, we addressed the hypothesis that specific functional proteins and chemical chaperones could improve ER capacity for Sp35:Fc folding reactions, increase secretion rate and/or relieve host cells from ER stress. We employed cell/process engineering by co-expressing a variety of molecular chaperones or UPR transactivators with Sp35:Fc, as well as a range of chemicals and hypothermic condition. We observed that Sp35:Fc production could be improved via two distinct modes; (i) increase in qP correlated to repression of µ, and (ii) stimulation of µ with general reduction in qP. In this regard, genes and chemicals could work synergistically to provide an optimal solution. Overall, this study illustrates that effective cell line and process development for DTE protein production requires a synergistic combination of vector, cell and process engineering strategies designed to alleviate cellular bottlenecks simultaneously, enabling the host cell to attain both high qP and cell density. Using two clonal variants and combinations of cell and process engineering, the transient Sp35:Fc production yield could be increased by more than six-fold. Rapid, high-throughput predictive mathematical tools would be particularly valuable in assessing the relative/synergistic impact of different engineering interventions.

6 citations


Cites background from "A GFP-based method facilitates clon..."

  • ..., 2012) and growth factors (Freimark et al., 2010; Meng et al., 2000), thus enabling easy, rapid identifications of high producers....

    [...]

  • ...Often, there is a high correlation between clone production of GFP and (easy-to-express) protein of interest including MAb (Davies et al., 2013; Kim et al., 2012) and growth factors (Freimark et al., 2010; Meng et al., 2000), thus enabling easy, rapid identifications of high producers....

    [...]

References
More filters
Journal ArticleDOI
TL;DR: The GFP originally cloned from the jellyfish Aequorea victoria has several nonoptimal properties including low brightness, a significant delay between protein synthesis and fluorescence development, and complex photoisomerization, but can be re-engineered by mutagenesis to ameliorate these deficiencies and shift the excitation and emission wavelengths, creating different colors and new applications.

1,550 citations

Journal ArticleDOI
TL;DR: The main result of this study was that the morphological and structural features of the lipopolyamine-DNA complexes did not depend on plasmid DNA length, while their gene transfer capacity was affected by the size of plasmids which were sandwiched between the lipid bilayers.
Abstract: Clinical applications of gene therapy mainly depend on the development of efficient gene transfer vectors. Large DNA molecules can only be transfected into cells by using synthetic vectors such as cationic lipids and polymers. The present investigation was therefore designed to explore the physicochemical properties of cationic lipid-DNA particles, with plasmids ranging from 900 to 52 500 bp. The colloidal stability of the lipoplexes formed by complexing lipopolyamine micelles with plasmid DNA of various lengths, depending on the charge ratio, resulted in the formation of three domains, respectively corresponding to negatively, neutrally and positively charged lipoplexes. Lipoplex morphology and structure were determined by the physicochemical characteristics of the DNA and of the cationic lipid. Thus, the lamellar spacing of the structure was determined by the cationic lipid and its spherical morphology by the DNA. The main result of this study was that the morphological and structural features of the lipopolyamine-DNA complexes did not depend on plasmid DNA length. On the other hand, their gene transfer capacity was affected by the size of plasmid DNA molecules which were sandwiched between the lipid bilayers. The most effective lipopolyamine-DNA complexes for gene transfer were those containing the shortest plasmid DNA.

273 citations


Additional excerpts

  • ...and the larger size of pTriEx2-neo [15, 16]....

    [...]

Journal ArticleDOI
TL;DR: There is an increasing need for methods for the selection of mammalian cell lines stably expressing recombinant products at high levels in an efficient, cost-effective and high-throughput manner.

229 citations


"A GFP-based method facilitates clon..." refers background in this paper

  • ...A key step in the generation of cell lines for the efficient production of recombinant proteins is the selection of high-producer clones following transfection and selection [1]....

    [...]

Journal ArticleDOI
TL;DR: The fluorescent signal from stable recombinant CHO cell lines expressing the green fluorescent protein (GFP) at high levels with biomass or cell number is correlated, extending the use of fluorescent proteins to applications and assays where cell growth rates are important.
Abstract: This study correlates the fluorescent signal from stable recombinant CHO cell lines expressing the green fluorescent protein (GFP) at high levels with biomass or cell number, extending the use of fluorescent proteins to applications and assays where cell growth rates are important. Using a standard fluorometer, growth of these cells can be quantified noninvasively in multiwell plates, and because signals are obtained without preparation, the same culture samples can be measured repeatedly. Even with a small relative change in biomass, the specific growth rate can be determined in a few hours. The dynamics of cell populations can now be studied with high sensitivity, low error rate, and minimum sample preparation.

210 citations


"A GFP-based method facilitates clon..." refers background in this paper

  • ...[9, 11]), so that no physical connection between the expression of the two proteins exists....

    [...]

Journal ArticleDOI
TL;DR: Findings indicate that the expression of VEGF may confer on cells the ability to grow in vivo in the absence of transformation by purely paracrine mechanisms.
Abstract: Vascular endothelial growth factor (VEGF) is a mitogen with a specificity for endothelial cells in vitro and an angiogenic inducer in vivo. We tested the hypothesis that VEGF may confer on expressing cells a growth advantage in vivo. Dihydrofolatereductase--Chinese hamster ovary cells were transfected with expression vectors which direct the constitutive synthesis of VEGF. Neither the expression nor the exogenous administration of VEGF stimulated anchorage-dependent or anchorage-independent growth of Chinese hamster ovary cells in vitro. However, VEGF-expressing clones, unlike control cells, demonstrated an ability to proliferate in nude mice. Histologic examination revealed that the proliferative lesions were compact, well vascularized, and nonedematous. Ultrastructural analysis revealed that capillaries within the lesions were of the continuous type. These findings indicate that the expression of VEGF may confer on cells the ability to grow in vivo in the absence of transformation by purely paracrine mechanisms. Since VEGF is a widely distributed protein, this property may have relevance for a variety of physiological and pathological proliferative processes.

165 citations


"A GFP-based method facilitates clon..." refers background in this paper

  • ...This clone thus already performs in the same range as previously described ones based on the CHO-DHFR system (101–520 μg/L [18])....

    [...]